Medication intended to reduce selected muscle spasms or overactivity; effects and risks vary by drug.
Understanding the approach
A muscle relaxant is a medicine used for selected painful contractions or forms of spasticity. The category includes different products. A drug for neurological spasticity does not necessarily address the same problem as a brief treatment for acute muscle spasm.
Indications and assessment
Assessment distinguishes perceived tension, cramp, weakness and neurological overactivity. Stiffness may be a response to pain rather than its main cause. Medical history, other medicines, work demands and driving influence the balance of benefit and risk.
Benefits, limitations and precautions
Short-term relief is possible in selected circumstances, but sustained benefit for chronic low back pain is uncertain. WHO does not recommend routine use for chronic primary low back pain. Drowsiness, dizziness, falls and interactions with other sedatives can limit usefulness, especially in older adults.
Place in the care pathway
TAGMED does not replace prescribing decisions. Physical care may accompany gradual return to movement when examination permits. Feeling more relaxed while taking a medicine does not mean that a herniation, stenosis or another underlying cause has been corrected.
Goals should be practical: walking farther, returning to a chosen activity or reducing symptoms that interfere with sleep. Improvement immediately after a session does not establish lasting benefit. Follow-up compares function with the starting point, records adverse effects and considers progress between appointments. An inadequate response should prompt a review of the clinical explanation or proposed approach, rather than an automatic extension of the same treatment.
Before starting, describe the outcome you want, treatments already tried and difficulties encountered. Ask how the response will be measured and when another option would be preferable. Available reports complement the discussion without replacing your current experience, priorities or preferences.
Frequently asked questions
Do all act directly on muscle?
No. Several work mainly through the nervous system.
Can they be combined with alcohol?
The combination may increase sedation and other risks; follow instructions to avoid it.
Is stiffness enough to justify treatment?
No. Its cause and functional effect should be assessed.
Are they automatically long-term treatment?
No. Duration and usefulness require review by the prescriber.
What if marked sleepiness occurs?
Avoid driving or hazardous activity and contact the professional; abnormal breathing is an emergency.
Conceptual diagram of clinical reasoning; not an anatomical drawing to scale.
Role of TAGMED care
This entry describes a medical or specialist option; it does not mean the intervention is performed at TAGMED. The clinic can discuss how its conservative services might fit into coordinated care, considering prescribed treatment, reports and specialist restrictions. Medication should not be stopped or changed on the basis of this page.
Medical references
- National Library of Medicine — MedlinePlus. Cyclobenzaprine: Drug Information.
- NIH — NIAMS. Back Pain: Diagnosis, Treatment, and Steps to Take.
- World Health Organization. WHO guideline for non-surgical management of chronic primary low back pain in adults.
References document the topic; their inclusion does not imply endorsement of TAGMED services by those organizations.
Educational information from The Spine Page. This entry does not replace an individual assessment. Documentary version: October 12, 2026. Sylvain Desforges, B.Sc., D.O., N.D., osteopath and naturopath.
TAGMED clinic contact details
For non-urgent consultations and information about available services.
Clinique TAGMED — Terrebonne
1150, rue Lévis, Suite 200
Terrebonne (Québec) J6W 5S6
450‑704‑4447
Clinique TAGMED — Montréal
1140, avenue Beaumont
Mont-Royal (Québec) H3P 3E5
1‑877‑672‑9060